滬電股份(002463.SZ)2020年激勵計劃擬授予3000萬份股票期權
格隆匯9月1日丨滬電股份(002463.SZ)披露2020年度股票期權激勵計劃(草案),擬授予激勵對象3000萬份股票期權,涉及的標的股票種類為人民幣A股普通股,約佔本次激勵計劃公告時公司股本總額17.24億股的1.74%。公司授予激勵對象股票期權的行權價格為16.85元/股。
本次激勵計劃授予的激勵對象共計628人,包括公司公告本次激勵計劃時在公司(含分子公司,下同)任職的董事、高級管理人員及骨幹員工。參與本次激勵計劃的激勵對象不包括公司監事、獨立董事、單獨或合計持有公司5%以上股份的股東或實際控制人及其配偶、父母、子女。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.